SCHEMBL18854331

SCHEMBL18854331

CC(C)C[C@H](NC(=O)CN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GHSR Q92847 11/20 0.56
▸ GRPR P30550 1/20 0.54
▸ REN P00797 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18854323 0.95 GHSR (0.59) GHSRREN
SCHEMBL18857765 0.94 GHSR (0.51) GHSRGRPR
SCHEMBL18854269 0.93 GHSR (0.60) GHSRGRPRREN
SCHEMBL18854322 0.88 IL23R (0.60) GHSRGRPRREN
SCHEMBL18854328 0.85 GHSR (0.49) GHSRGRPR
SCHEMBL18854276 0.84 GHSR (0.47) GHSRGRPR
SCHEMBL30824287 0.83 GHSR (0.63) GHSR
SCHEMBL18854326 0.83 GHSR (0.56) GHSRREN
SCHEMBL18854334 0.83 GHSR (0.56) GHSRREN
SCHEMBL18862442 0.83 GHSR (0.56) GHSRREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017083368-A9 TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 PFIZER INC. (US) 2018-04-12 — — WO disclosed
US-20170137801-A1 TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-05-18 — — US disclosed
WO-2017083368-A1 TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 PFIZER INC. (US) 2017-05-18 — — WO disclosed
Send feedback